EMG
COLL icon

Ellington Management Group’s Collegium Pharmaceutical COLL Stock Holding History

Ellington Management Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,900
Closed -$411K – 432
2018
Q3 		$411K Buy
+27,900
New +$495K 0.11% 247
2015
Q4 		– Sell
-27,300
Closed -$604K – 620
2015
Q3 		$604K Buy
+27,300
New +$494K 0.17% 172

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ellington Management Group's COLL Position: Q4 2018 in Review

Ellington Management Group sold out of Collegium Pharmaceutical (COLL) in Q4 2018, closing a stake of 27,900 shares — an estimated $411K sold.

Ellington Management Group first reported a position in COLL in Q3 2015 and held it in 2 quarters. The position peaked at $604K in Q3 2015. 120 funds tracked by Wall St. Rank hold COLL as of Q4 2018.

  • Ellington Management Group reported no remaining Collegium Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Ellington Management Group sold 27,900 Collegium Pharmaceutical shares in Q4 2018, an estimated $411K.
  • Ellington Management Group first reported a position in Collegium Pharmaceutical in Q3 2015 and held it in 2 quarters.
  • Ellington Management Group's Collegium Pharmaceutical position peaked at $604K in Q3 2015.
  • 120 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2018.

Based on Ellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.